Justin D. Gover
CIK 1754129 · Chief Executive Officer · last filed 2026-06-11
Justin D. Gover is a Chief Executive Officer who has filed 31 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for DSGN, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$8.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $137.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$137.8K
4
31
-$8.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DSGN | Director | — | $10.97 | — | $0 | 3 | 2026-06-11 |
| XENE | Director | 2,645 | $52.10 | $137.8K | $0 | 4 | 2026-06-03 |
| CMPS | Director | — | $12.08 | — | $0 | 2 | 2026-05-29 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Chief Executive Officer | 2,131,481 | $218.96 | $466.71M | -$8.20M | 21 | 2021-03-22 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2026-06-03 | XENE | Mixed | +2,645 | $0 | EDGAR |
| 2026-05-29 | CMPS | Grant (A) | — | $0 | EDGAR |
| 2026-01-05 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2025-09-10 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2025-07-30 | CMPS | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | XENE | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | XENE | Grant (A) | — | $0 | EDGAR |
| 2023-08-10 | XENE | Grant (A) | — | $0 | EDGAR |
| 2021-05-07 | — | Disp (D) | −2,546,129 | $0 |